Skip to Content

Colcrys Approval History

Colcrys (colchicine) is compound derived from the dried seeds of the autumn crocus or meadow saffron (Colchicum autumnale). Colcrys is approved for the prophylaxis and treatment of acute gout flares, and for the treatment of patients with familial Mediterranean fever.

Development History and FDA Approval Process for Colcrys

Oct 22, 2009Approval FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares
Jul 31, 2009Approval FDA Approves Colcrys (colchicine) for Acute Gout, Mediterranean Fever

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.